be able to conduct analysis on-orbit. Jeffrey Manber, Managing Director of NanoRacks said, "Having the SpectraMax M5e Reader on-orbit will allow researchers to undertake research with real-time results. It was difficult and time consuming to undertake quality, repetitive research projects before the completion of the International Space Station. A new era has begun, and researchers will be able to do quality work without the cloak of gravity."
In addition, researchers will use the reader to do sophisticated analysis of experiments in areas such as: biochemistry, molecular biology, stem cell and cancer research, immunology, enzymatic type studies, microbial growth, and endotoxin testing. Johnson said, "We believe this will be the first time ever that researchers will be able to see on-orbit reactions happening via the use of fluorescence polarization - this is breaking into new areas of sophisticated research."
"We are extremely pleased that NanoRacks has chosen the M5e Reader because of its robustness of features, ease-of-operation, and software that make it a clear choice for space-based researchers on the space station," said Mikey Kindler, Director of Marketing, BioResearch Products. "We look forward to working with NanoRacks in the months ahead to ensure that the M5e Reader will soon be operational in space."
Ultimately, the M5e Reader will join NanoRacks expanding line of commercial hardware on the space station, which includes microscopes, a centrifuge, and their research platforms - all designed to lead to a path to stimulate commercial usage of these products from the broader research community. Under the terms of the NASA service contract awarded to NanoRacks, the M5e Reader will be owned by NanoRacks. NASA sponsored researchers will have access to the unit while allowing NanoRacks to market the plate reader to commercial users. The Space Act Agreement with NASA's U.S. National Lab allows NanoRacks to develop, operate, and marke
Page: 1 2 3 4 Related biology technology :1
|SOURCE Molecular Devices, Inc.|
Copyright©2010 PR Newswire.
All rights reserved
. Reportlinker Adds Molecular Diagnostics Market: DNA Probes And Biochips2
. Reportlinker Adds Molecular Diagnostics Markets3
. BD Diagnostics Receives FDA Clearance for First Fully Automated Molecular Assays for HSV1 and HSV2 from Clinician-Collected External Anogenital Lesion Specimens4
. Reportlinker Adds World Market for Molecular Diagnostics: Potential and Reality, Whats Hot and Whats Not , The5
. Swift Biosciences Presents Highly Sensitive, Highly Specific qPCR Mutation Detection Data at 18th International Molecular Medicine Tri-Conference6
. Reportlinker Adds The 2011 Molecular Diagnostics Market: DNA Probes and Biochips -- New Product Development Opportunities and Business Expansion Strategies for Instrument and Reagent Suppliers7
. Reportlinker Adds The 2011 Molecular Diagnostics Market: DNA Probes and Biochips New Product Development Opportunities and Business Expansion Strategies for Instrument and Reagent Suppliers8
. Reportlinker Adds Molecular Diagnostics Markets9
. Reportlinker Adds Molecular Diagnostics - Technologies, Markets and Companies10
. The Future of Molecular Diagnostics: Innovative Technologies Driving Market Opportunities in Personalized Medicine11
. bioMerieux and Biocartis Sign Strategic Partnership in Molecular Diagnostics